Oncotarget is a multidisciplinary journal that publishes oncology papers online on a weekly basis. The journal is traditional, and it sometimes publishes articles or journals on special demand. The journal was established back in 2010 by impact journals, and it has since enjoyed much success. It has also increased the subject après that are discussed.The mission of the journalists is to provide scientific results rapidly and widely. They also aim at maximizing the impact that research has through insightful review and they as well allow any exceptional discoveries to be shared in a quick manner. Other than that, Oncotarget aims to remove the border that exists between different specialties and to link the various biomedical sciences.Oncotarget is led by the most prominent scientists, making the reports credible. The journal is also useful as it helps all the researchers to make a positive contribution to science. The primary goal is to ensure that all living things live without diseases.
Oncotarget is the citation that reports on aging and publishes papers that have high impact in all areas concerning aging. They also conduct research related to aging in areas such as genetics, cellular, senescence, age related diseases among other topics. Among the members of the advisory board are Michael Hall, Mikhail Blagosklonny, and Brian Kennedy.There also exists a pathology section that is headed by Michael Lisanti, who was formerly the editor in chief of the American Journal of Pathology. The pathology section is more advantageous than other sections because it has a higher impact factor. It also allows people to submit papers that were rejected by other journal review boards.
However, in such cases, one is asked to provide the reviews and the rebuttals from the other teams. The other advantage is that the pathology journals have a rapid publication in comparison to other magazines. Moreover, the accepted papers are published within five days.Oncotarget also addresses the issue of therapy where the pathological issues are concerned. It also addresses all types of cancers and treatment procedures that are used to improve the patient’s condition. Issues such as quality of life, satisfaction, and adherence to procedures are also concerned.